Hashtag
Men's Weekly

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

SYDNEY, June 30, 2021/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide an update on recent progress with its two pipeline assets, paxalisib and EVT801.

Key Points

  • GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now...

Read more: Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

More Articles ...

  1. LyondellBasell announces acquisition of PolyPacific Polymers Sdn. Bhd. in Malaysia
  2. IR expands Cisco portfolio with new support for Webex Meetings
  3. SOR Powers Bluetooth Sensor Device with Moisture
  4. AirCar's flying car completes first ever inter-city flight
  5. Nintex Announces Finalists of the 2021 Nintex Partner Awards

Health & Wellness

How to Pick the Best Hair Loss Treatment for You

Hashtag.net.au - avatar Hashtag.net.au

Hair loss invades the lives of millions worldwide, wreaking havoc with self-esteem and self-image. With so many to choose from—whether it is topical treatment and medications or newer surgical metho...

Understanding Root Canal Treatment: What You Need to Know

Hashtag.net.au - avatar Hashtag.net.au

Image by pvproductions on Freepik When it comes to dental health, many people hear the term root canal treatment and immediately feel a bit uneasy. This procedure often gets a bad reputation, but und...

Telehealth Could be the Catalyst for Better Heart Health in Australia

Hashtag.net.au - avatar Hashtag.net.au

Image by stockking on Freepik Heart disease is one of the leading causes of death in Australia despite decades of advancements in medicine and health education campaigns. More than 400 Australians ...